The Putative Antilipogenic Role of NRG4 and ERBB4: First Expression Study on Human Liver Samples
Background: Epidermal growth factor receptor 4 (ERBB4) and neuregulin 4 (NRG4) have been shown to reduce steatosis and prevent the development of non-alcoholic steatohepatitis in mouse models, but little to nothing is known about their role in non-alcoholic fatty liver disease (NA...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
IMR Press
2024-12-01
|
| Seri Bilgileri: | Frontiers in Bioscience-Landmark |
| Konular: | |
| Online Erişim: | https://www.imrpress.com/journal/FBL/29/12/10.31083/j.fbl2912414 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|